What is it? Why is it important?

Various laws and ordinances regulate and address data protection issues:

  • The Federal Act on Data Protection (FADP)
  • Data protection in clinical research is governed by the Human Research Act (HRA) including its 4 ordinances:
    • The Clinical Trials Ordinance (ClinO)
    • The Human Research Ordinance (HRO)
    • The Clinical Trials with Medical Device Ordinance (ClinO-MD)
    • The Organisation Ordinance (OrgO-HRA)

 

Based on the HRA:

  • Data confidentiality must be guaranteed at all times
  • Any recorded study data including implemented changes as well as persons that document the data must be traceable (e.g. based on an audit-trail)
  • Access to study data must be protected with regulated access control measures (e.g. access rights)

 

The FADP

  • Aims to protect the privacy and the fundamental rights of persons and their processed data.
  • Defines data processing as any operation that handles personal data in particular the collection, storage, use, revision, disclosure, archiving or destruction of data
  • Applies to any data that is processed

What do I need to do?

As a SP-INV,

  • Ensure data confidentiality and traceability
  • Limit the number of staff given access to study data (e.g. regulated access to data entry)
  • Access should be based on required circumstances necessary to perform delegated task(s)
  • Code study data at the time of data collection in order to protect participant identity
  • Guarantee that no data has been collected without the participant consent

 

Participants freely consent to the use of their data by signing a consent form (ICF), and have the right to:

  • Be informed and view any data collected on their behalf
  • Have their data corrected in the event of incorrect entries
  • Dissent to their data being used for further research
  • Have their data anonymised upon revocation of consent

 

Where can I get help?

Your local CTU can support you with experienced staff regarding this topic

External Links

Swissethics – see in particular

  • Topics / Other topics / Coding of trial subjects accepted by swissethics

Federal Act on Data Protection (FADP) – see in particular

  • Art. 1 Purpose
  • Art. 2 Scope

SCTO Regulatory Affairs – see in particular

  • RAW Issue 1, April 2019,  Essential information on data protection

References

ICH GCP E6(R2) – see in particular guidelines

  • 2.11 Confidentiality of records
  • 4.9 Records and reports

Swiss Law

HRA – see in particular chapter and articles

  • Chapter 10 Transparency and data protection
  • Art. 8 Right to receive information
  • Art. 16 Informed consent
  • Art. 17 Consent to further use for research

ClinO – see in particular article

  • Art. 9 Consequences of revocation of consent

HRO – see in particular article

  • Art. 10. Consequences of revocation of consent
Abbreviations
  • ClinO – Clinical Trials Ordinance
  • CTU – Clinical Trials Unit
  • FADP – Federal Act of Data Protection
  • HRA – Human Research Act
  • ICF - Informed Consent Form
  • ICH GCP – International Council for Harmonisation - Good Clinical Practice
  • HRO – Human Research Ordinance
  • SP-INV – SP Investigator
Basic ↦ Data Management ↦ Regulatory Requirements ↦ Swiss Law
Study
Basic

Provides some background knowledge and basic definitions

Basic Monitoring
Basic Drug or Device
Concept

Starts with a study idea

Ends after having assessed and evaluated study feasibility

Concept Statistic Methodology
Concept Drug or Device
Development

Starts with confidence that the study is feasible

Ends after having received ethics and regulatory approval

Development Drug or Device
Set-Up

Starts with ethics and regulatory approval

Ends after successful study initiation

Set-Up Ethics and Laws
Set-Up Statistic Methodology
Set-Up Quality and Risk
Set-Up Drug or Device
Conduct

Starts with participant recruitment

Ends after the last participant has completed the last study visit

Conduct Statistic Methodology
Conduct Drug or Device
Completion

Starts with last study visit completed

Ends after study publication and archiving

Completion Statistic Methodology
Completion Drug or Device
Current Path (click to copy): Basic ↦ Data Management ↦ Regulatory Requirements ↦ Swiss Law

Please note: the Easy-GCS tool is currently under construction.